Table 2 Primary and secondary outcomes in the intention-to-treat (ITT) population
Outcome | Study arm | |||||
|---|---|---|---|---|---|---|
Control group T1: n = 97, T2: n = 82 | Intervention group T1: n = 105, T2: n = 85 | |||||
Time | Median | IQR | Median | IQR | p | |
T1 | SPPB | 3.00 | [2.00–5.00] | 4.00 | [3.00–5.00] | 0.308a |
Frailty scale | 5.00 | [4.00–6.00] | 5.00 | [3.00–6.00] | 0.281b | |
Clock test | 3.00 | [2.00–4.00] | 3.00 | [2.00–4.00] | 0.799 b | |
EQ-5D 5L VAS | 55.00 | [45.00–75.00] | 50.00 | [45.00–70.00] | 0.355 b | |
FES-I | 28.00 | [20.00–38.00] | 27.00 | [21.00–37.00] | 0.805 b | |
T2 | SPPB | 3.00 | [2.00–5.00] | 4.00 | [2.00–5.00] | 0.225 a |
Frailty scale | 6.00 | [4.00–6.00] | 5.00 | [4.00–6.00] | 0.912 b | |
Clock drawing test | 3.00 | [2.00–4.00] | 3.00 | [2.00–4.00] | 0.661 b | |
EQ5D 5L VAS | 50.00 | [47.50–72.50] | 54.00 | [50.00–75.00] | 0.425 b | |
FES-I | 27.00 | [20.00–38.00] | 26.00 | [20.00–35.00] | 0.964 b | |